Technical progress in circulating tumor DNA analysis using next generation sequencing.

[1]  S. Chin,et al.  Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer , 2019, Science Translational Medicine.

[2]  F. Bidard,et al.  Microfluidic extraction and digital quantification of circulating cell-free DNA from serum , 2019, Sensors and Actuators B: Chemical.

[3]  J. V. van Meerbeeck,et al.  Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol , 2019, Cancers.

[4]  Shan X. Wang,et al.  Highly sensitive detection of DNA hypermethylation in melanoma cancer cells. , 2019, Biosensors & bioelectronics.

[5]  C. Brennan,et al.  Tracking Tumor Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid , 2018, Nature.

[6]  N. Pavlidis,et al.  Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary. , 2018, European journal of cancer.

[7]  O. Delattre,et al.  Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis , 2018, International journal of cancer.

[8]  Elizabeth K. Schmidt,et al.  Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS) , 2018, Genome research.

[9]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[10]  Natalie S. Fox,et al.  The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression , 2018, Cell.

[11]  Jesse J. Salk,et al.  Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations , 2018, Nature Reviews Genetics.

[12]  Maximilian Diehn,et al.  Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. , 2018, Archives of pathology & laboratory medicine.

[13]  Nikhil Wagle,et al.  Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Ash A. Alizadeh,et al.  Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer Discovery.

[15]  P. Laurent-Puig,et al.  Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) , 2017, Clinical Cancer Research.

[16]  Ashwini Naik,et al.  Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.

[17]  Lincoln D. Stein,et al.  Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing , 2017, Nature Protocols.

[18]  K. Nan,et al.  Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer , 2016, Oncotarget.

[19]  A. Vincent-Salomon,et al.  Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. , 2016, Clinical chemistry.

[20]  M. Erlander,et al.  A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  L. Hui,et al.  Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. , 2016, Gene.

[22]  R. Strausberg,et al.  Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer , 2016, Science Translational Medicine.

[23]  P. Laktionov,et al.  Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients , 2016, PloS one.

[24]  A. Heger,et al.  UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.

[25]  Lincoln D. Stein,et al.  Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing , 2016, Nucleic acids research.

[26]  Ash A. Alizadeh,et al.  Integrated digital error suppression for improved detection of circulating tumor DNA , 2016, Nature Biotechnology.

[27]  Jorge S. Reis-Filho,et al.  Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer , 2015, Science Translational Medicine.

[28]  R. Strausberg,et al.  Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Mårten Fernö,et al.  Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease , 2015, EMBO molecular medicine.

[30]  H. Nielsen,et al.  Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery , 2015, Gut.

[31]  Brendan F. Kohrn,et al.  Detecting ultralow-frequency mutations by Duplex Sequencing , 2014, Nature Protocols.

[32]  David M. Thomas,et al.  Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing , 2014, BMC Medical Genomics.

[33]  Franck Molina,et al.  Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA , 2014, Nature Medicine.

[34]  Ash A. Alizadeh,et al.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.

[35]  P. Laurent-Puig,et al.  Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. , 2013, Clinical chemistry.

[36]  Jeffrey A. Hussmann,et al.  High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing , 2013, Proceedings of the National Academy of Sciences.

[37]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[38]  J. Carpten,et al.  Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs , 2013 .

[39]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[40]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[41]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[42]  P. Jiang,et al.  High Resolution Size Analysis of Fetal DNA in the Urine of Pregnant Women by Paired-End Massively Parallel Sequencing , 2012, PloS one.

[43]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[44]  K. Kinzler,et al.  Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.

[45]  S. Linnarsson,et al.  Counting absolute numbers of molecules using unique molecular identifiers , 2011, Nature Methods.

[46]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[47]  Frank Diehl,et al.  Detection and quantification of mutations in the plasma of patients with colorectal tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Shifu Chen,et al.  Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data. , 2018, Methods in molecular biology.

[49]  P. Laurent-Puig,et al.  [Digital PCR compartmentalization I. Single-molecule detection of rare mutations]. , 2015, Medecine sciences : M/S.